Hecolin vaccine: long-term efficacy against HEV for a three-dose regimen. Abravanel F, Lhomme S. Lancet 2024 Feb 19:S0140-6736(23)02455-8. doi: 10.1016/S0140-6736(23)02455.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Abravanel F, Lhomme S. Hecolin vaccine: long-term efficacy against HEV for a three-dose regimen. Lancet 2024 Feb 19:S0140-6736(23)02455-8. doi: 10.1016/S0140-6736(23)02455.
PMID: 38387471